Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter study from 2016 to 2023

Wenyan Xu1, Bite Yang2, Lang Lin3

  • 1Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.

Helicobacter
|November 20, 2023
PubMed

Insights

Antibiotic resistance in Helicobacter pylori (H. pylori) is high in Chinese children, particularly to clarithromycin and metronidazole, with increasing trends. Susceptibility remains high for amoxicillin, furazolidone, and tetracycline.

Area of Science:

  • Pediatric infectious diseases
  • Antimicrobial resistance surveillance
  • Gastroenterology

Background:

  • Helicobacter pylori (H. pylori) infection is a global health concern, especially in pediatric populations.
  • Antibiotic resistance significantly impacts treatment efficacy for H. pylori infections.
  • Understanding regional and temporal trends in H. pylori antibiotic resistance is crucial for effective management.

Purpose of the Study:

  • To determine the antibiotic resistance patterns of H. pylori strains in Chinese children.
  • To assess resistance to clarithromycin, metronidazole, amoxicillin, levofloxacin, furazolidone, and tetracycline.
  • To identify trends and regional variations in H. pylori antibiotic resistance over an 8-year period.

Main Methods:

  • A multicenter, retrospective study involving 3074 H. pylori isolates from pediatric patients across China (2016-2023).
  • Gastric mucosa biopsies were collected during upper gastrointestinal endoscopy.
  • Antibiotic susceptibility testing was performed using the agar dilution method.

Main Results:

  • High resistance rates were observed for clarithromycin (36.7%) and metronidazole (77.3%).
  • Levofloxacin resistance was 16.6%, while amoxicillin, furazolidone, and tetracycline showed very low resistance (<0.3%).
  • Resistance to clarithromycin and metronidazole significantly increased over time, with notable regional variations. Multi-drug resistance was found in 36.3% of isolates.

Conclusions:

  • H. pylori resistance to clarithromycin and metronidazole is a significant and growing problem in Chinese children.
  • Levofloxacin resistance is also a concern, whereas amoxicillin, furazolidone, and tetracycline remain effective.
  • Continuous monitoring of H. pylori antibiotic resistance patterns in pediatric populations is essential for guiding clinical practice.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
415
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
134
Antibiotic Selection00:57

Antibiotic Selection

Overview
54.3K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
436
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
95
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
178